Recorded live from BIO 2026 in San Diego, Gil sits down with Sam Chung, Senior Vice President of Government Relations and External Affairs at California Life Sciences (CLS), to examine a stark and urgent question: Is America&#x27;s leadership in biomedical innovation still a given? Against the backdrop of NIH funding cuts, a 34% drop in San Diego venture capital, California&#x27;s post-2030 R&amp;D tax credit rollback, and China&#x27;s explicit, government-backed commitment to dominating the global life sciences sector, Chung delivers a data-driven, candid, and at times sobering assessment of the headwinds threatening what he calls the &quot;crown jewel&quot; of the California economy. The conversation covers clinical trial timelines, IP migration, talent flight, and what policymakers at both the state and federal level must do to preserve American biomedical leadership before it becomes a historical footnote.<br><br>To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”.<br><br>Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Health UnaBASHEd: BIO 2026 China, Clinical Trials, and California's Moment of Reckoning

Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com

This is Health Unabashed broadcasting live on Healthcare NOW Radio. Health Unabashed is where healthcare meets innovation, insight and impact. We engage top industry minds to explore the future of health and wellness from visionary thinking to sustainable models, policy reform to frontline delivery and ultimately the real world impact on public health. I'm Greg Masters, co-host and executive producer alongside my partner in conversation, the ever curious,

digital health aficionado, author, editor, global thought leader and industry steward, Gil Bash. Together we bring you the people, ideas and movements reshaping healthcare, not with hype but with purpose and persistence. Now with no further delay, Gil, the mic is yours. Greg, as always, the most gracious introduction. I want to thank you. I want to thank you also for introducing our wonderful guest today. We have Sam Chung with us from the

California Life Sciences Association, California Life Sciences Association, California Life Sciences Association, California-based organization representing the life science industry, obviously one of the state's most precious economic centers. They issued a very, very important statement yesterday. Sam and I are going to explore that a little bit, what it means. He's really someone who's very, very, very suited to speak to this issue. And we're going to talk about that. We're

broadcasting live from bio right now. So it's, it's a combination of innovation, policy, politics, patient advocacy, all of that is being discussed. Sam, I want to welcome you here. Thank you. And I want to thank you for zipping over from your last session. I understand you were on the panel. You were presenting just a few moments ago. I was, it was a great panel moderated by the governor's office of economic development. So we are proud to be a

Health UnaBASHEd: BIO 2026 China, Clinical Trials, and California's Moment of Reckoning

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Health UnaBASHEd: BIO 2026 China, Clinical Trials, and California's Moment of Reckoning

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.